Literature DB >> 27559701

Usefulness of the Delta Neutrophil Index as a Promising Prognostic Marker of Acute Cholangitis in Emergency Departments.

Hyunchul Kim1, Taeyoung Kong, Sung Phil Chung, Jung Hwa Hong, Jong Wook Lee, Youngseon Joo, Dong Ryul Ko, Je Sung You, Incheol Park.   

Abstract

PURPOSE: Recent technological advances have led to analyses of the delta neutrophil index (DNI), which reflects the fraction of circulating immature granulocytes, using specific automated blood cell analyzers. We evaluated the significance of the DNI as a prognostic marker for early severity in patients with acute cholangitis.
METHODS: We retrospectively analyzed patients initially diagnosed with acute cholangitis at emergency department admission, followed by diagnostic confirmation, during a set period. The DNI was determined on each day of hospitalization. Clinical outcomes were the incidence of shock requiring vasopressor/inotrope and 28-day mortality.
RESULTS: We included 461 patients who met our inclusion criteria. According to multivariate Cox proportional hazard models, higher DNI at admission (hazard ratio [HR]: 1.102; 95% confidence interval [CI]: 1.053-1.153; P < 0.001), day 1 (HR: 1.069; 95% CI: 1.018-1.122; P = 0.008), and day 2 (HR: 1.118; 95% CI: 1.053-1.186; P < 0.001) were significant risk factors for 28-day mortality. Among patients with acute cholangitis, a DNI > 4.9% at admission (HR: 5.632; 95% CI: 1.977-16.045; P = 0.001) and day 1 (HR, 9.973; 95% CI: 2.666-37.302; P < 0.001) and higher DNI ( > 2.5%) on day 2 (HR, 16.942; 95% CI: 2.15-133.496; P = 0.007) were associated with increased 28-day mortality.
CONCLUSION: Higher DNI levels are predictive markers of hemodynamic instability and 28-day mortality in patients with acute cholangitis. The accuracy of DNI for predicting hemodynamic instability and 28-day mortality is superior to that of other parameters.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27559701     DOI: 10.1097/SHK.0000000000000722

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

1.  Usefulness of the delta neutrophil index to predict 30-day mortality in patients with ST segment elevation myocardial infarction.

Authors:  Taeyoung Kong; Tae Hoon Kim; Yoo Seok Park; Sung Phil Chung; Hye Sun Lee; Jung Hwa Hong; Jong Wook Lee; Je Sung You; Incheol Park
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

Review 2.  Cholangitis: Diagnosis, Treatment and Prognosis.

Authors:  Amir Houshang Mohammad Alizadeh
Journal:  J Clin Transl Hepatol       Date:  2017-09-07

3.  The delta neutrophil index (DNI) as a prognostic marker for mortality in adults with sepsis: a systematic review and meta-analysis.

Authors:  Chiwon Ahn; Wonhee Kim; Tae Ho Lim; Youngsuk Cho; Kyu-Sun Choi; Bo-Hyoung Jang
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

4.  The delta neutrophil index predicts development of multiple organ dysfunction syndrome and 30-day mortality in trauma patients admitted to an intensive care unit: a retrospective analysis.

Authors:  Taeyoung Kong; Yoo Seok Park; Hye Sun Lee; Sinae Kim; Jong Wook Lee; Je Sung You; Hyun Soo Chung; Incheol Park; Sung Phil Chung
Journal:  Sci Rep       Date:  2018-11-30       Impact factor: 4.379

5.  Delta Neutrophil Index for the Prediction of Prognosis in Acute Gastrointestinal Diseases; Diagnostic Test Accuracy Meta-Analysis.

Authors:  Hae Min Jeong; Chang Seok Bang; Jae Jun Lee; Gwang Ho Baik
Journal:  J Clin Med       Date:  2020-04-15       Impact factor: 4.241

6.  Identification of the robust predictor for sepsis based on clustering analysis.

Authors:  Jae Yeon Jang; Gilsung Yoo; Taesic Lee; Young Uh; Juwon Kim
Journal:  Sci Rep       Date:  2022-02-11       Impact factor: 4.379

7.  Clinical Significance of the Neutrophil-Lymphocyte Ratio as an Early Predictive Marker for Adverse Outcomes in Patients with Acute Cholangitis.

Authors:  Sang-Hoon Lee; Tae-Yoon Lee; Jong-Hyeon Jeong; Young-Koog Cheon
Journal:  Medicina (Kaunas)       Date:  2022-02-09       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.